Table 2.

Left Ventricular Area at Risk

	N	Body weight (g)	LV (g)	AAR (g)	AAR/LV (%)
CON	7	2769 ± 357	3.61 ± 0.28	1.37 ± 0.36	38 ± 8
He (1 Cycle)	7	2736 ± 196	3.45 ± 0.23	1.24 ± 0.11	36 ± 5
He (3 Cycles)	7	2526 ± 143	3.90 ± 0.26	1.30 ± 0.07	34 ± 2
He (5 Cycles)	6	2647 ± 462	3.55 ± 0.34	1.23 ± 0.14	35 ± 2
SB21 (0.2 mg/kg)	6	2590 ± 294	3.71 ± 0.22	1.61 ± 0.14	44 ± 4
SB21 (0.6 mg/kg)	7	2671 ± 415	3.56 ± 0.31	1.27 ± 0.08	36 ± 3
He (1 Cycle) + SB21 (0.2 mg/kg)	6	2503 ± 133	3.50 ± 0.34	1.30 ± 0.08	37 ± 3
He (1 Cycle) + SB21 (0.2 mg/kg) + ATR (5 mg/kg)	6	2702 ± 132	3.88 ± 0.40	1.44 ± 0.27	37 ± 6
PIF (1.5 mg/kg)	7	2563 ± 152	3.36 ± 0.49	1.25 ± 0.22	37 ± 4
PIF (3.0 mg/kg)	6	2438 ± 103	3.09 ± 0.25	1.22 ± 0.04	40 ± 2
He (1 Cycle) + PIF (1.5 mg/kg)	6	2428 ± 105	3.07 ± 0.19	1.15 ± 0.11	38 ± 3
He (1 Cycle) + PIF (1.5 mg/kg) ± ATR (5 mg/kg)	7	2720 ± 189	4.19 ± 0.27	1.66 ± 0.15	40 ± 4

Data are mean ± sd.

LV = left ventricle; AAR = area at risk; CON = control; He = helium; SB21 = SB213763; PIF = pifithrin-α; ATR = atractyloside.